Zobrazeno 1 - 10
of 52
pro vyhledávání: '"S, Hulkko"'
Autor:
Laura S. S. Hulkko, Ariel E. Turcios, Stéphane Kohnen, Tanmay Chaturvedi, Jutta Papenbrock, Mette Hedegaard Thomsen
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Salt-tolerant halophytes have shown potential for biorefinery and agricultural use in salt-affected soils, increasing the value of marginal lands. They could provide a bio-based source for compounds obtained from the petrochemical industry o
Externí odkaz:
https://doaj.org/article/970a228fb4744d48a66b530a34060536
Publikováno v:
Applied Sciences, Vol 12, Iss 2, p 840 (2022)
Halophytes are salt-tolerant plants, and they have been utilised as healthy, nutritious vegetables and medicinal herbs. Various studies have shown halophytes to be rich in health-beneficial compounds with antioxidant activity, anti-inflammatory and a
Externí odkaz:
https://doaj.org/article/4c1e0492b28146f1af37caf459d659a7
Publikováno v:
Urology. 43:427-434
OBJECTIVE. To investigate the distribution and production of alpha 1-antichymotrypsin (ACT) and prostate-specific antigen (PSA) in benign hyperplastic and malignant prostatic tissue, respectively. METHODS. Using monoclonal anti-ACT and anti-PSA IgGs
Publikováno v:
Prostate cancer and prostatic diseases. 2(3)
We have developed a direct immunofluorescence technique utilising chelates of the lanthanide ions europium and terbium conjugated to monoclonal IgGs (Mabs) against prostate-specific antigen (PSA) and alpha-1-antichymotrypsin (ACT) for the detection a
Publikováno v:
Contraception. 58(2)
In this prospective randomized clinical trial, two long-term contraceptive implants were studied with respect to hemostasis and liver function in 86 healthy young women. The two implants used were Implanon, containing the progestagen etonogestrel (th
Publikováno v:
Human reproduction (Oxford, England). 10(6)
To evaluate the efficacy and safety of nafarelin before hysterectomy in a prospective placebo-controlled trial, we randomized 188 pre-menopausal women with uterine fibroids (n = 111), menometrorrhagia (n = 58) or pelvic pain (n = 19) to receive eithe
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 16:275-281
The present study was carried out to measure lipid and protein levels in serum of healthy women during treatment with a new oral contraceptive combination containing 0.075 mg desogestrel (Org 2969. 17α-ethinyl-18-methyl-11-methylene-4-estren-17-ol)
Autor:
I. Lumiala, K. Rhen, M. Saranen, K. Käär, M. Korhonen, K. Lauslahti, T. Tarkkila, L. Viinikka, E. Hirvonen, M. Weijers, Roel Assendorp, Olof Widholm, K. Järvi, U. Alapiessa, P. Virkkunen, S. Hulkko, Reijo Punnonen, O. Pora, Aimo Ruokonen, P. Liukko
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 58:1-21
A new orally active progestin ORG 2969 (13-ethyl-ll-methylene-1819-dinor-17 alpha-pregn-4-en-20-yn-17-ol) was studied in combination with ethinyl estradiol (EE) to determine its ability to suppress ovulation and its effects on peripheral functions in
Publikováno v:
Current Medical Research and Opinion. 5:247-251
A low-dose contraceptive containing 1 mg of lynestrenol and .05 mg of ethinyl estradiol was studied over 12 cycles in 11 healthy fertile women volunteers. The subjects were aged 20-30 years. Measurements were taken of urinary luteinizing hormone (LH)
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 105(3)